Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can change the day you take Mounjaro. The key rule is straightforward: your next injection must fall no sooner than three days after your last one, and ideally no more than four or five days later. Once you've chosen a new day that fits, you stay on that schedule going forward. These are prescription-only medicines, so any change to your routine is worth a quick word with your prescriber if you have questions specific to your situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people assume that shifting their Mounjaro injection day means restarting the dose titration, or that it will somehow reset their progress. It doesn't. The medicine is already in your system; tirzepatide has a half-life of around five days, so a modest shift in timing doesn't wipe out what's already working. What matters is the gap between your last injection and your next one — not the calendar date itself.
The NHS guidance on tirzepatide confirms that Mounjaro can be taken on any day of the week, and that if you want to change your injection day you simply ensure at least three days have passed since the previous dose. That minimum three-day gap is the practical guardrail. Dose too closely together and you're more likely to experience nausea or other gastrointestinal discomfort; space things out comfortably and the transition is usually unremarkable.
There's no clinical requirement to tell your prescriber before you switch days, though it's sensible to note the change so that your next clinical review reflects accurate timing. If you're unsure about anything specific to your dose or health history, a quick message to your prescribing team is always worthwhile.
Say you've been injecting every Tuesday. Life has rearranged itself, perhaps payday lands differently, you've got a holiday coming up, or Monday just fits your routine better now. To move to Monday, you'd simply wait until the Monday that falls at least three days after your most recent Tuesday dose. That one Monday injection bridges the gap. From that point, Monday is your new weekly day.
Moving the other direction (to a Thursday, say) works the same way. If your last injection was Tuesday, you can go as early as Friday (three days later) or take it on Thursday the following week. The window you're aiming for is three to seven days between doses. Staying closer to seven days is ideal for consistency, but small adjustments within that range are generally well-tolerated.
If you're thinking about whether you can change the day you take your Mounjaro and how that fits into the broader picture of managing your weight, it's worth knowing that consistency of weekly dosing matters more than which specific day you choose. The body responds to the medicine's steady presence, not to a particular slot in the diary.
For most people, shifting the injection day by a few days doesn't produce any noticeable change in how they feel. If anything, the side-effect profile of Mounjaro is most pronounced when a new dose level begins, not when the timing shifts slightly within an established dose. The common gastrointestinal effects (nausea, changes in appetite, occasional loose stools) relate more to dose escalation than to day-switching.
That said, if your new schedule accidentally shortens the gap to fewer than three days, you may notice stronger-than-usual nausea. The simple fix is to wait the full three days before injecting. If you're ever uncertain whether you've left enough time, the Mounjaro Patient Information Leaflet (available on the electronic Medicines Compendium) sets out the exact guidance, and our prescribers are available seven days a week if you'd like to check.
One question that occasionally comes up is whether changing injection timing can affect the menstrual cycle. There's some evidence that tirzepatide can alter period patterns as part of its broader hormonal effects, but this isn't related to which day of the week you inject.
Mounjaro's flexibility around day-switching is genuinely useful during holidays or disrupted weeks. If you're travelling and want to dose on a slightly different day to avoid carrying refrigerated medicine through an airport, the three-to-seven-day window gives you reasonable room to manoeuvre. You can shift the day you take Mounjaro by a day or two without treating it as a significant event, provided the minimum gap is respected.
Storage during travel is a separate consideration, the pen must be kept within the temperature range specified in the leaflet, so a cool bag for longer journeys is sensible. For a fuller picture of tirzepatide, including how it works and what the clinical evidence shows, the tirzepatide overview covers the detail. And if you're still exploring whether Mounjaro is the right option for you, or have questions such as whether Jardiance is the same as Mounjaro, our clinical team at nume reviews every consultation personally, not via an automated system. When you're ready, you can start your free consultation and have your questions answered the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.